The mission of the Institut Jules Bordet's Department of Internal Medicine is to assume responsibilitiy regarding:
- The oncological emergencies room
- The diagnosis and guidance unit.
- The infectious diseases clinic.
- Providing training in internal medicine for medical students and doctors training to be a specialist during the core years of internal medicine studies and higher training in internal medicine.
- Organising, with senior doctors from other specialities, the hospital's medical activity and support for undergraduate and postgraduate students
The Department of Internal Medicine offers expertise in the various fields of internal medicine while specialising in caring for patients suffering from oncological diseases:
- Oncological emergencies
- Infectious diseases
Every autumn the Department of Internal Medicine organizes an international meeting in French that is dedicated specifically to the severe complications that occur in patients suffering from a cancerous disease.
The department managers have developed two websites dedicated to cancer complications: www.oncorea.com for acute problems and www.pneumocancero.com for chronic problems (with particular focus on thoracic oncology).
The department has a continuous intake of medical students (Master's) and trainee specialists (internal medicine and sister disciplines) who follow training courses in internal medicine and in the department's more specific sectors. They are supported during seminars and specific tours.
In addition, the responsible doctors participate actively in the teaching of medical semiology, internal medicine clinical practice for the ULB's Master's in medicine, and the ULB's Master's specialising in internal medicine.
Our team
Head of department
Prof. Anne-Pascale Meert
Intensive care and oncological emergencies
Dr Bogdan Grigoriu, head of clinic
Dr Maxime Ilzkovitz, resident
Infectious diseases clinic
Dr Aspasia Georgala, head of clinic
Dr Angela Loizidou, deputy head of clinic
Dr Michaela Raimo
10/11/2023
Scientific publications
Evaluation of Endocan as a Treatment for Acute Inflammatory Respiratory Failure.
Authors : Hureau M, Portier L, Prin M, de Nadai P, Balsamelli J, Tsicopoulos A, Mathieu D, Lassalle P, Grigoriu B, Gaudet A, De Freitas Caires N
Year : 2023
Journal : Cells
Volume : 12
Erratum to When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study" [Bull. Cancer 109 (2022) 916-24]."
Authors : Meert AP, Toffart AC, Picard M, Jaubert P, Gibelin A, Bauer P, Mokart D, Van de Louw A, Hatzl S, Moreno-Gonzales G, Rousseau-Bussac G, Bruneel F, Montini L, Moreau AS, Carpentier D, Seguin A, Hemelaar P, Azoulay E, Lemiale V
Year : 2023
Journal : Bull Cancer
Sepsis-associated coagulopathy in onco-hematology patients presenting with thrombocytopenia: a multicentric observational study.
Authors : Lemiale V, Mabrouki A, Miry L, Mokart D, Pène F, Kouatchet A, Mayaux J, Bruneel F, Perez P, Meert AP, Moreau AS, Benoit D, Darmon M, Zafrani L, Clere-Jehl R
Year : 2023
Journal : Leuk Lymphoma
Volume : 64
Pages : 197-204
[Respiratory cancer diseases: Which role for intensive care ?].
Authors : Berghmans T, Meert AP
Year : 2023
Journal : Rev Mal Respir
Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy.
Authors : Jungels C, Pita JM, Costante G
Year : 2023
Journal : Curr Opin Oncol
Volume : 35
Pages : 1-9